effects of semaglutide on kidneys flow trial kidney outcomes 2024 nejm hazard ratio Long-term in obesity and cardiovascular disease in the SELECT of semaglutide with and – Semaglutide in patients with overweight – Research shows semaglutide — commonly

Ask your prescriber if adjusting may help

If nausea remains a concern, speak with your provider about taking anti-nausea medication or adjusting your dose

Key Points: Prescription only available after a free online consultation with a UK prescriber Once-weekly injection with an easy-to-use pen Clinically proven to support significant weight reduction when combined with diet and exercise Long-term treatment with gradual dose increases over 1620 weeks and ongoing maintenance if effective Suitable for most adults 18 years and over, subject to a professional assessment Clinical trials show that people using Wegovy alongside lifestyle changes achieved meaningful, sustained weight loss over time

additional contraception is recommended for 4 weeks after starting and after each dose increase